☆ 4.7 Editorial Material

Editorial: C. elegans as an emerging model of pharmacological innovation

FRONTIERS IN PHARMACOLOGY (2022)

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds against Polyglutamine-mediated Neurotoxicity

Qiangqiang Wang et al.

Summary: The paper introduces generalized experimental protocols to assess the neuroprotective capacity of test compounds against Huntington's disease using established polyQ transgenic Caenorhabditis elegans models.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2021)

添加到收藏夹

Article Geriatrics & Gerontology

The Traditional Formula Kai-Xin-San Alleviates Polyglutamine-Mediated Neurotoxicity by Modulating Proteostasis Network in Caenorhabditis elegans

Lingyun Xiao et al.

REJUVENATION RESEARCH (2020)

添加到收藏夹

Article Cell Biology

Astragalus Polysaccharide Suppresses 6-Hydroxydopamine-Induced Neurotoxicity in Caenorhabditis elegans

Haifeng Li et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Inhibition of polyglutamine-mediated proteotoxicity by Astragalus membranaceus polysaccharide through the DAF-16/FOXO transcription factor in Caenorhabditis elegans

Hanrui Zhang et al.

BIOCHEMICAL JOURNAL (2012)

添加到收藏夹

Editorial: C. elegans as an emerging model of pharmacological innovation

相关参考文献

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds against Polyglutamine-mediated Neurotoxicity

The Traditional Formula Kai-Xin-San Alleviates Polyglutamine-Mediated Neurotoxicity by Modulating Proteostasis Network in Caenorhabditis elegans

Astragalus Polysaccharide Suppresses 6-Hydroxydopamine-Induced Neurotoxicity in Caenorhabditis elegans

Inhibition of polyglutamine-mediated proteotoxicity by Astragalus membranaceus polysaccharide through the DAF-16/FOXO transcription factor in Caenorhabditis elegans

导出引文

分享论文